HRTX logo

Heron Therapeutics (HRTX) Short Term Debt

Annual Short Term Debt

$3.08 M
+$381.00 K+14.14%

31 December 2023

HRTX Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$3.25 M
+$55.00 K+1.72%

30 September 2024

HRTX Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HRTX Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.1%+8.3%
3 y3 years-69.4%-0.1%
5 y5 years-32.8%-54.1%

HRTX Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-69.4%+27.2%-0.1%+34.4%
5 y5 years-69.4%+27.2%-69.5%+34.4%
alltimeall time-89.3%+2975.0%-88.8%+3149.0%

Heron Therapeutics Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$3.25 M(+1.7%)
June 2024
-
$3.19 M(+1.8%)
Mar 2024
-
$3.14 M(+2.0%)
Dec 2023
$3.08 M(+14.1%)
$3.08 M(+2.5%)
Sept 2023
-
$3.00 M(+16.2%)
June 2023
-
$2.58 M(-6.6%)
Mar 2023
-
$2.76 M(+2.5%)
Dec 2022
$2.69 M(+11.5%)
$2.69 M(+2.8%)
Sept 2022
-
$2.62 M(+2.8%)
June 2022
-
$2.55 M(+2.6%)
Mar 2022
-
$2.48 M(+2.8%)
Dec 2021
$2.42 M(-76.0%)
$2.42 M(-25.7%)
Sept 2021
-
$3.25 M(+2.8%)
June 2021
-
$3.16 M(-70.3%)
Mar 2021
-
$10.64 M(+5.8%)
Dec 2020
$10.05 M(+33.1%)
$10.05 M(+5.2%)
Sept 2020
-
$9.55 M(+4.9%)
June 2020
-
$9.10 M(+4.7%)
Mar 2020
-
$8.69 M(+15.1%)
Dec 2019
$7.55 M(+65.1%)
$7.55 M(+6.7%)
Sept 2019
-
$7.08 M(+4.0%)
June 2019
-
$6.80 M(-0.7%)
Mar 2019
-
$6.85 M(+49.8%)
Dec 2018
$4.57 M(-84.1%)
$4.57 M(+5.4%)
Sept 2018
-
$4.34 M(-85.1%)
June 2018
-
$29.11 M(+0.8%)
Mar 2018
-
$28.89 M(+0.7%)
Dec 2017
$28.68 M(+885.4%)
$28.68 M(+724.0%)
Sept 2017
-
$3.48 M(+6.0%)
June 2017
-
$3.29 M(+6.1%)
Mar 2017
-
$3.10 M(+6.4%)
Dec 2016
$2.91 M(+31.0%)
$2.91 M(+6.6%)
Sept 2016
-
$2.73 M(+6.8%)
June 2016
-
$2.56 M(+7.1%)
Mar 2016
-
$2.39 M(+7.5%)
Dec 2015
$2.22 M(+39.0%)
$2.22 M(+7.8%)
Sept 2015
-
$2.06 M(+8.3%)
June 2015
-
$1.90 M(+8.8%)
Mar 2015
-
$1.75 M(+9.4%)
Dec 2014
$1.60 M
$1.60 M(+10.2%)
Sept 2014
-
$1.45 M(+11.0%)
DateAnnualQuarterly
June 2014
-
$1.31 M(+12.2%)
Mar 2014
-
$1.16 M(+13.6%)
Dec 2013
$1.02 M(+108.3%)
$1.02 M(+15.4%)
Sept 2013
-
$888.00 K(+17.8%)
June 2013
-
$754.00 K(+21.2%)
Mar 2013
-
$622.00 K(+26.4%)
Dec 2012
$492.00 K(+377.7%)
$492.00 K(+377.7%)
Dec 2011
$103.00 K(-88.4%)
$103.00 K(-89.2%)
June 2000
-
$954.70 K(+3.5%)
Mar 2000
-
$922.40 K(+3.5%)
Dec 1999
$891.10 K(-71.3%)
$891.10 K(-10.9%)
Sept 1999
-
$1.00 M(0.0%)
June 1999
-
$1.00 M(-16.7%)
Mar 1999
-
$1.20 M(-61.3%)
Dec 1998
$3.10 M(+24.0%)
$3.10 M(-16.2%)
Sept 1998
-
$3.70 M(-11.9%)
June 1998
-
$4.20 M(-8.7%)
Mar 1998
-
$4.60 M(+84.0%)
Dec 1997
$2.50 M(+66.7%)
$2.50 M(0.0%)
Sept 1997
-
$2.50 M(+13.6%)
June 1997
-
$2.20 M(+22.2%)
Mar 1997
-
$1.80 M(+20.0%)
Dec 1996
$1.50 M(+66.7%)
$1.50 M(-44.4%)
Sept 1996
-
$2.70 M(+17.4%)
June 1996
-
$2.30 M(+53.3%)
Mar 1996
-
$1.50 M(+66.7%)
Dec 1995
$900.00 K(-59.1%)
$900.00 K(+28.6%)
Sept 1995
-
$700.00 K(-66.7%)
June 1995
-
$2.10 M(-4.5%)
Mar 1995
-
$2.20 M(0.0%)
Dec 1994
$2.20 M(+633.3%)
$2.20 M(+633.3%)
Sept 1994
-
$300.00 K(0.0%)
June 1994
-
$300.00 K(0.0%)
Mar 1994
-
$300.00 K(0.0%)
Dec 1993
$300.00 K(0.0%)
$300.00 K(0.0%)
Sept 1993
-
$300.00 K(0.0%)
June 1993
-
$300.00 K(0.0%)
Mar 1993
-
$300.00 K(0.0%)
Dec 1992
$300.00 K(+200.0%)
$300.00 K(-90.0%)
Sept 1990
-
$3.00 M(0.0%)
June 1990
-
$3.00 M(+2900.0%)
Dec 1987
$100.00 K
$100.00 K

FAQ

  • What is Heron Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Heron Therapeutics?
  • What is Heron Therapeutics annual short term debt year-on-year change?
  • What is Heron Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Heron Therapeutics?
  • What is Heron Therapeutics quarterly short term debt year-on-year change?

What is Heron Therapeutics annual short term debt?

The current annual short term debt of HRTX is $3.08 M

What is the all time high annual short term debt for Heron Therapeutics?

Heron Therapeutics all-time high annual short term debt is $28.68 M

What is Heron Therapeutics annual short term debt year-on-year change?

Over the past year, HRTX annual short term debt has changed by +$381.00 K (+14.14%)

What is Heron Therapeutics quarterly short term debt?

The current quarterly short term debt of HRTX is $3.25 M

What is the all time high quarterly short term debt for Heron Therapeutics?

Heron Therapeutics all-time high quarterly short term debt is $29.11 M

What is Heron Therapeutics quarterly short term debt year-on-year change?

Over the past year, HRTX quarterly short term debt has changed by +$250.00 K (+8.34%)